Published in PLoS One on March 23, 2010
Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets. Acta Pharmacol Sin (2010) 1.40
SOCS1, a Negative Regulator of Cytokine Signals and TLR Responses, in Human Liver Diseases. Gastroenterol Res Pract (2010) 1.04
Viral exploitation of host SOCS protein functions. J Virol (2010) 1.01
Hepatitis B virus induces expression of antioxidant response element-regulated genes by activation of Nrf2. J Biol Chem (2010) 0.99
Association of chronic viral hepatitis B with insulin resistance. World J Gastroenterol (2012) 0.84
Interactions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical Impact. Dig Dis Sci (2015) 0.81
Hepatic STAMP2 decreases hepatitis B virus X protein-associated metabolic deregulation. Exp Mol Med (2012) 0.77
The investigation of glucose metabolism and insulin secretion in subjects of chronic hepatitis B with cirrhosis. Int J Clin Exp Pathol (2015) 0.76
Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions. Oncol Lett (2016) 0.75
Hepatitis B Virus Activates Signal Transducer and Activator of Transcription 3 Supporting Hepatocyte Survival and Virus Replication. Cell Mol Gastroenterol Hepatol (2017) 0.75
Hepatitis B Virus Infection Status is more prevalent in patients with type 2 diabetes. J Diabetes Investig (2016) 0.75
Hepatitis C virus induces a pre-diabetic state by directly impairing hepatic glucose metabolism in mice. J Biol Chem (2017) 0.75
Inflammation and metabolic disorders. Nature (2006) 33.33
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (1994) 26.02
Inflammation and insulin resistance. J Clin Invest (2006) 18.76
Stat3 as an oncogene. Cell (1999) 17.39
A central role for JNK in obesity and insulin resistance. Nature (2002) 17.27
Hepatitis B virus infection. N Engl J Med (1997) 14.50
Chronic hepatitis B. Hepatology (2007) 13.75
Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol (2006) 10.67
SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol (2007) 6.89
Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell (2000) 5.92
High-level hepatitis B virus replication in transgenic mice. J Virol (1995) 5.81
Cytokine receptor signalling. Nature (1995) 5.46
The insulin signaling system. J Biol Chem (1994) 5.25
Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action. J Biol Chem (2001) 5.12
SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol (2003) 4.90
SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem (2002) 4.84
Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology (2003) 4.10
SOCS proteins: negative regulators of cytokine signaling. Stem Cells (2001) 3.40
SOCS: physiological suppressors of cytokine signaling. J Cell Sci (2000) 2.69
Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem (2003) 2.67
Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol Metab (2006) 2.52
Cloning and characterization of novel CIS family genes. Biochem Biophys Res Commun (1997) 2.51
Regulation of gene expression by insulin. Physiol Rev (1996) 2.51
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology (2008) 2.46
Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J Hepatol (1999) 2.46
Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes (2003) 2.40
Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology (2007) 2.25
Inhibitors of cytokine signal transduction. J Biol Chem (2003) 2.10
Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc Natl Acad Sci U S A (1999) 2.04
Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol (2001) 1.98
Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress. Mol Cell Biol (2001) 1.93
Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis. Oncogene (2006) 1.92
Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling. Proc Natl Acad Sci U S A (1998) 1.90
Molecular functions and biological roles of hepatitis B virus x protein. Cancer Sci (2006) 1.72
Hepatitis B virus X protein induces lipogenic transcription factor SREBP1 and fatty acid synthase through the activation of nuclear receptor LXRalpha. Biochem J (2008) 1.69
Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells. Hepatology (2004) 1.57
HBx protein of hepatitis B virus activates Jak1-STAT signaling. J Biol Chem (1998) 1.50
Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroenterology (2007) 1.45
Woodchuck hepatitis virus X protein is present in chronically infected woodchuck liver and woodchuck hepatocellular carcinomas which are permissive for viral replication. J Virol (1996) 1.35
The dual function of hepatic SOCS3 in insulin resistance in vivo. Genes Cells (2007) 1.28
Hepatitis B virus X protein: structure, function and biology. Intervirology (1999) 1.21
Increased frequency of HCV and HBV infection in type 2 diabetic patients. Diabetes Res Clin Pract (2000) 1.16
Insulin resistance and steatosis in humans. Diabetes Metab (2008) 1.11
Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis. Diabetes Metab (2001) 0.94
Transcriptional repression of the gluconeogenic gene PEPCK by the orphan nuclear receptor SHP through inhibitory interaction with C/EBPalpha. Biochem J (2007) 0.93
Insulin resistance in chronic hepatitis B and C. Indian J Gastroenterol (2007) 0.93
cDNA microarray analysis of HBV transgenic mouse liver identifies genes in lipid biosynthetic and growth control pathways affected by HBV. J Med Virol (2005) 0.93
Dual function of interleukin-1beta for the regulation of interleukin-6-induced suppressor of cytokine signaling 3 expression. J Biol Chem (2004) 0.91
Regulation of suppressor of cytokine signaling 3 (SOC3) by growth hormone in pro-B cells. Mol Endocrinol (2007) 0.89
Hepatitis B and fatty liver: causal or coincidental? J Gastroenterol Hepatol (2008) 0.86
Hepatitis B virus X protein regulates transactivation activity and protein stability of the cancer-amplified transcription coactivator ASC-2. Hepatology (2003) 0.78
A Mammalian bromodomain protein, brd4, interacts with replication factor C and inhibits progression to S phase. Mol Cell Biol (2002) 2.51
Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J Immunol (2007) 1.80
Hepatitis B virus X protein induces lipogenic transcription factor SREBP1 and fatty acid synthase through the activation of nuclear receptor LXRalpha. Biochem J (2008) 1.69
Amyloidogenic peptide oligomer accumulation in autophagy-deficient β cells induces diabetes. J Clin Invest (2014) 1.17
Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway. FEBS Lett (2009) 1.08
Genistein sensitizes TRAIL-resistant human gastric adenocarcinoma AGS cells through activation of caspase-3. Cancer Lett (2007) 0.99
Ca2+/calmodulin-dependent protein phosphatase calcineurin mediates the expression of iNOS through IKK and NF-kappaB activity in LPS-stimulated mouse peritoneal macrophages and RAW 264.7 cells. Biochem Biophys Res Commun (2004) 0.96
Molecular mechanism of hypoxia-mediated hepatic gluconeogenesis by transcriptional regulation. FEBS Lett (2005) 0.93
Bile acid induces expression of COX-2 through the homeodomain transcription factor CDX1 and orphan nuclear receptor SHP in human gastric cancer cells. Carcinogenesis (2008) 0.91
Hepatitis C virus NS5A protein increases hepatic lipid accumulation via induction of activation and expression of PPARgamma. FEBS Lett (2009) 0.91
Activating transcription factor-2 mediates transcriptional regulation of gluconeogenic gene PEPCK by retinoic acid. Diabetes (2002) 0.89
Induction of apoptosis and inhibition of telomerase activity by aqueous extract from Platycodon grandiflorum in human lung carcinoma cells. Pharmacol Res (2005) 0.87
Activating transcription factor 2 increases transactivation and protein stability of hypoxia-inducible factor 1alpha in hepatocytes. Biochem J (2009) 0.87
Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress. Diabetologia (2014) 0.87
Interactions between activating signal cointegrator-2 and the tumor suppressor retinoblastoma in androgen receptor transactivation. J Biol Chem (2003) 0.86
SHP (small heterodimer partner) suppresses the transcriptional activity and nuclear localization of Hedgehog signalling protein Gli1. Biochem J (2010) 0.85
Interaction and functional cooperation of the cancer-amplified transcriptional coactivator activating signal cointegrator-2 and E2F-1 in cell proliferation. Mol Cancer Res (2003) 0.85
Activation and interaction of ATF2 with the coactivator ASC-2 are responsive for granulocytic differentiation by retinoic acid. J Biol Chem (2004) 0.83
Coactivator ASC-2 mediates heat shock factor 1-mediated transactivation dependent on heat shock. FEBS Lett (2004) 0.83
Phosphorylation of NF-kappa B by calmodulin-dependent kinase IV activates anti-apoptotic gene expression. Biochem Biophys Res Commun (2003) 0.82
Bile acids increase hepatitis B virus gene expression and inhibit interferon-alpha activity. FEBS J (2010) 0.82
The SDF-1alpha/CXCR4 axis induces the expression of fatty acid synthase via sterol regulatory element-binding protein-1 activation in cancer cells. Carcinogenesis (2010) 0.80
Characterization of Paralichthys olivaceus peroxisome proliferator-activated receptor-α gene as a master regulator of flounder lipid metabolism. Gen Comp Endocrinol (2011) 0.80
A methyl jasmonate derivative, J-7, induces apoptosis in human hepatocarcinoma Hep3B cells in vitro. Toxicol In Vitro (2010) 0.78
Molecular cloning and characterization of olive flounder (Paralichthys olivaceus) peroxisome proliferator-activated receptor gamma. Gen Comp Endocrinol (2009) 0.78
Phosphorylation of the large subunit of replication factor C is associated with adipocyte differentiation. FEBS J (2007) 0.78
Hepatitis B virus X protein regulates transactivation activity and protein stability of the cancer-amplified transcription coactivator ASC-2. Hepatology (2003) 0.78
Homeodomain transcription factor CDX1 is required for the transcriptional induction of PPARgamma in intestinal cell differentiation. FEBS Lett (2008) 0.77
beta-Lapachone-induced apoptosis is associated with activation of caspase-3 and inactivation of NF-kappaB in human colon cancer HCT-116 cells. Anticancer Drugs (2003) 0.77
Tumor suppressor protein VHL inhibits Hedgehog-Gli activation through suppression of Gli1 nuclear localization. FEBS Lett (2013) 0.75
The binding of hepatitis B virus X protein to glioma-associated oncogene homologue 1 and its biological characterization in vitro. Appl Biochem Biotechnol (2011) 0.75
Induction of apoptosis and G2/M arrest by N-methyl-N'-nitro-N-nitrosoguanidine in human prostate carcinoma cells. Mutat Res (2004) 0.75
Generation of expressed sequence tags for immune gene discovery and marker development in the sea squirt, Halocynthia roretzi. J Microbiol Biotechnol (2008) 0.75
Identification of softness syndrome-associated candidate genes and DNA sequence variation in the sea squirt, Halocynthia roretzi. Mar Biotechnol (NY) (2008) 0.75